A carregar...
Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
Tyrosine kinase inhibitors (TKIs) are used to target dysregulated signaling pathways in virtually all hematologic malignancies. Many of the targeted signaling pathways are also essential in nonmalignant immune cells. The current coronavirus severe acute respiratory syndrome coronavirus 2 pandemic ca...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7871903/ https://ncbi.nlm.nih.gov/pubmed/33560402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003768 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|